Johannes Geiger

916 total citations
20 papers, 684 citations indexed

About

Johannes Geiger is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Johannes Geiger has authored 20 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Genetics and 3 papers in Surgery. Recurrent topics in Johannes Geiger's work include RNA Interference and Gene Delivery (11 papers), Virus-based gene therapy research (8 papers) and CRISPR and Genetic Engineering (6 papers). Johannes Geiger is often cited by papers focused on RNA Interference and Gene Delivery (11 papers), Virus-based gene therapy research (8 papers) and CRISPR and Genetic Engineering (6 papers). Johannes Geiger collaborates with scholars based in Germany, France and Switzerland. Johannes Geiger's co-authors include Carsten Rudolph, Manish K. Aneja, Christian Plank, Elizabeth R. Balmayor, Olga Mykhaylyk, Martijn van Griensven, Günther Hasenpusch, Senta Üzgün, Christian A. Koch and Christof Maucksch and has published in prestigious journals such as Biomaterials, Advanced Functional Materials and Journal of Controlled Release.

In The Last Decade

Johannes Geiger

20 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johannes Geiger Germany 15 469 190 92 68 62 20 684
Günther Hasenpusch Germany 11 918 2.0× 331 1.7× 89 1.0× 76 1.1× 70 1.1× 14 1.1k
Mustafa M. Munye United Kingdom 14 543 1.2× 196 1.0× 66 0.7× 32 0.5× 139 2.2× 17 784
Chengyi He China 13 359 0.8× 148 0.8× 118 1.3× 68 1.0× 13 0.2× 33 687
Alexandra S. Piotrowski-Daspit United States 15 633 1.3× 112 0.6× 198 2.2× 106 1.6× 73 1.2× 28 1.0k
Elisa Brunette United States 10 571 1.2× 205 1.1× 177 1.9× 128 1.9× 69 1.1× 14 777
S H Cheng United Kingdom 8 643 1.4× 296 1.6× 85 0.9× 15 0.2× 67 1.1× 9 784
S. Morley United Kingdom 14 384 0.8× 146 0.8× 64 0.7× 30 0.4× 112 1.8× 22 923
David Onion United Kingdom 14 474 1.0× 333 1.8× 92 1.0× 48 0.7× 31 0.5× 43 847

Countries citing papers authored by Johannes Geiger

Since Specialization
Citations

This map shows the geographic impact of Johannes Geiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Geiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Geiger more than expected).

Fields of papers citing papers by Johannes Geiger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Geiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Geiger. The network helps show where Johannes Geiger may publish in the future.

Co-authorship network of co-authors of Johannes Geiger

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Geiger. A scholar is included among the top collaborators of Johannes Geiger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Geiger. Johannes Geiger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Björhall, Karin, Ulf Gehrmann, Lisa Öberg, et al.. (2024). Transcriptional Dynamics of NRF2 Overexpression and KEAP1-NRF2 Inhibitors in Human Cell Line and Primary Lung Cells. Antioxidants. 13(8). 924–924. 1 indexed citations
2.
Vega, Rodolfo E. De la, Martijn van Griensven, Wen Zhang, et al.. (2022). Efficient healing of large osseous segmental defects using optimized chemically modified messenger RNA encoding BMP-2. Science Advances. 8(7). eabl6242–eabl6242. 62 indexed citations
3.
Geiger, Johannes, et al.. (2021). Small Molecules Enhance Reprogramming of Adult Human Dermal Fibroblasts to Dorsal Forebrain Precursor Cells. Stem Cells and Development. 31(3-4). 78–89. 5 indexed citations
4.
Geiger, Johannes, Manish K. Aneja, Mauro Alini, et al.. (2020). Comparison of different transfection methods for mRNA delivery in articular joint cells. Osteoarthritis and Cartilage. 28. S197–S198. 1 indexed citations
5.
Juillerat, Alexandre, Markus Hildenbeutel, Manuel Rhiel, et al.. (2020). Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV‐1 Infection. Biotechnology Journal. 16(1). e2000023–e2000023. 17 indexed citations
6.
7.
Herbst, Elmar, Florian B. Imhoff, Peter Foehr, et al.. (2018). Chemically Modified Messenger RNA: Modified RNA Application for Treatment of Achilles Tendon Defects. Tissue Engineering Part A. 25(1-2). 113–120. 6 indexed citations
8.
Aneja, Manish K., et al.. (2018). Maximizing the Translational Yield of mRNA Therapeutics by Minimizing 5′-UTRs. Tissue Engineering Part A. 25(1-2). 69–79. 54 indexed citations
9.
Connor, Bronwen, Ruth Monk, Kevin Lee, et al.. (2018). Conversion of adult human fibroblasts into neural precursor cells using chemically modified mRNA. Heliyon. 4(11). e00918–e00918. 26 indexed citations
10.
Miskey, Csaba, Elena Almarza, Valentina Poletti, et al.. (2018). Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors. Molecular Therapy. 26(4). 1137–1153. 52 indexed citations
11.
Aneja, Manish K., Christian Dohmen, D Emrich, et al.. (2017). Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA. Molecular Therapy — Nucleic Acids. 7. 350–365. 55 indexed citations
12.
Geiger, Johannes, et al.. (2017). Tendon healing induced by chemically modified mRNAs. European Cells and Materials. 33. 294–307. 19 indexed citations
13.
Balmayor, Elizabeth R., Johannes Geiger, Christian A. Koch, et al.. (2016). Modified mRNA for BMP-2 in Combination with Biomaterials Serves as a Transcript-Activated Matrix for Effectively Inducing Osteogenic Pathways in Stem Cells. Stem Cells and Development. 26(1). 25–34. 47 indexed citations
14.
Balmayor, Elizabeth R., Johannes Geiger, Manish K. Aneja, et al.. (2016). Chemically modified RNA induces osteogenesis of stem cells and human tissue explants as well as accelerates bone healing in rats. Biomaterials. 87. 131–146. 91 indexed citations
15.
Hahn, Tobias, Johannes Geiger, Xavier Blase, et al.. (2015). Does Excess Energy Assist Photogeneration in an Organic Low‐Bandgap Solar Cell?. Advanced Functional Materials. 25(8). 1287–1295. 31 indexed citations
16.
Geiger, Johannes, Olga Mykhaylyk, Frank Wiekhorst, et al.. (2012). Magnetized Aerosols Comprising Superparamagnetic Iron Oxide Nanoparticles Improve Targeted Drug and Gene Delivery to the Lung. Pharmaceutical Research. 29(5). 1308–1318. 46 indexed citations
17.
Geiger, Johannes, Manish K. Aneja, Günther Hasenpusch, et al.. (2010). Targeting of the prostacyclin specific IP1 receptor in lungs with molecular conjugates comprising prostaglandin I2 analogues. Biomaterials. 31(10). 2903–2911. 15 indexed citations
18.
Geiger, Johannes, Günther Hasenpusch, Senta Üzgün, et al.. (2009). Targeting of the β2-adrenoceptor increases nonviral gene delivery to pulmonary epithelial cells in vitro and lungs in vivo. Journal of Controlled Release. 135(3). 234–241. 45 indexed citations
19.
Aneja, Manish K., Johannes Geiger, Senta Üzgün, et al.. (2009). Optimization of Streptomyces bacteriophage φC31 integrase system to prevent post integrative gene silencing in pulmonary type II cells. Experimental & Molecular Medicine. 41(12). 919–919. 7 indexed citations
20.
Geiger, Johannes, Manish K. Aneja, & Carsten Rudolph. (2009). Vectors for pulmonary gene therapy. International Journal of Pharmaceutics. 390(1). 84–88. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Günther Hasenpusch Breakdown of academic impact, for papers by Mustafa M. Munye Breakdown of academic impact, for papers by Chengyi He Breakdown of academic impact, for papers by Alexandra S. Piotrowski-Daspit Breakdown of academic impact, for papers by Elisa Brunette Breakdown of academic impact, for papers by S H Cheng Breakdown of academic impact, for papers by S. Morley Breakdown of academic impact, for papers by David Onion
Rankless by CCL
2026